维普期刊资源整合服务平台（V6.5）

66篇 您的检索式：作者名="HAURA EB"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Pharmacogenomics strate- gies for developing customized chemotherapy in non-small cell lung cancer 显示文摘	Sarries C Haura EB Roig B	2002	Pharmacogenomics2002，3，6：	1
2	Mechanisms of disease:insights into the emerging role of signal transducers and activators of transcription in cancer显示文摘	Haura EB Turkson J Jove R	2005	Nat Clin Pract Oncol2005，2，：	1
3	Targeting epidermal growth factor receptor:central signaling kinase in lung cancer显示文摘	Yoshida T Zhang GL Haura EB		0，，05：	1
4	Mechanisms of disease : Insights into the emerging role of signal transducers and activators of transcription in cancer显示文摘	Haura EB Turkson J JoveR	2005	Nat Clin Pract Oncol2005，2，6：	1
5	Polymorphisms of the DNA genes Erccl and lung cancer risk显示文摘	Sarries C Haura EB Roig B	2001	Cancer Epidemiol Biomark Prevent2001，10，2：	1
6	Src kinases as therapeutic targetsfor cancer 显示文摘	Kim LC Song L Haura EB	2009	Nat Rev Clin Oncol2009，6，10：	1
7	Phase I / II study of the Src inhibitor dasatinib in combination with er- lotinib in advanced non-small-cell lung cancer 显示文摘	Haura EB Tanvetyanon T Chiappori A	2010	J Clin On- col2010，28，8：	1
8	Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer 显示文摘	Haura EB Turkson J Jove R	2005	Nat Clin Pract Oncol2005，2，6：	1
9	Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer显示文摘	Sarries C Haura EB Roig B	2002	Pharmacogenomics2002，3，6：	1
10	Src kinases as therapeutic targets for cancer显示文摘	Kim LC Song L Haura EB		0，，10：	1
11	Mechanisms of disease:Insights into the emerging role of signal transducers and activators of transcription in cancer显示文摘	Haura EB Turkson J Jove R	2005	Nat Clin Pract Oncol2005，2，6：	1
12	Phase Ⅰ / Ⅱ study of the Src inhibitor dasatinib in combination with erlotinib in ad- vanced non small-cell lung cancer显示文摘	Haura EB Tanvetyanon T Chiappori A	2010	J Clin Oncol2010，28，8：	1
13	SRC and STAT pathway显示文摘	Haura EB	2006	J Thorac Oncol2006，1，5：	1
14	Src kinases as therapeutic targetsfor cancer 显示文摘	Kim LC Song L Haura EB	2009	Nat Rev Clin Oncol2009，6，10：	1
15	Mechanisms ofdisease:Insights into the emerging role of signal transducers and activators of transcription in cancer显示文摘	Haura EB Turkson J Jove R	2005	Nat Clin Pratt Oncol2005，2，6：	1
16	Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer显示文摘	Sarries C Haura EB Roig B	2002	Pharmacogenomics2002，3，6：	1
17	Mechanisms of disease:Insights into the emerging role of signal transducers and activators of transcription in cancer显示文摘	Haura EB Turkson J Jove R	2005	Nat Clin Prsct Oncol2005，2，6：	1
18	Phase Ⅰ / Ⅱ study of the Src inhibitor dasatinib in combination with erlotinib in advanced nonl-small-cell lung cancer 显示文摘	HAURA EB TANVETYANON T CHIAPPORI A	2010	J Clin Onco12010，28，8：	1
19	Mechanisms of disease:insights into the emerging role of signal transducers and activators of transcription in cancer显示文摘	Haura EB Turkson J Jove R	2005	Nat Clin Pract Oncol2005，2，6：	1
20	Src kinases as therapeutic targets for cancer显示文摘	Kim LC Song LX Haura EB	2009	Nat Rev Clin Oncol2009，6，10：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示